Skip to main content
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 2002 Oct 23;128(11):596–602. doi: 10.1007/s00432-002-0388-4

Src/ERK but not phospholipase D is involved in keratinocyte growth factor-stimulated secretion of matrix metalloprotease-9 and urokinase-type plasminogen activator in SNU-16 human stomach cancer cell

Eun-Young Shin 1, Eun-Kyung Ma 2, Chi-Kyung Kim 2, Sahng-June Kwak 3, Eung-Gook Kim 1
PMCID: PMC12164420  PMID: 12458339

Abstract

Abstract

Purpose. We investigated the signaling pathway for keratinocyte growth factor (KGF)-induced invasion using human stomach cancer cell line, SNU-16.

Methods. Alterations in the activities of Src, extracellular signal-regulated kinase (ERK), and phospholipase D (PLD) were measured using [γ-32P] ATP for autophosphorylation of Src, phospho-specific ERK antibody, and [9,10-3H] myristic acid, respectively, while herbimycin A, PD98059 and butan-1-ol were used to inhibit their activities. Matrix metalloproteases (MMPs) and urokinase-type plasminogen activator (uPA) were quantified with zymography and Matrigel-coated Transwell was employed to estimate the invasiveness of SNU-16 cells.

Results. Src, ERK, and PLD were activated in response to KGF treatment, and inhibition of these enzymes – by their specific inhibitors – decreased KGF-induced invasion in a dose-dependent manner. However, only inhibition of Src and ERK could block KGF-stimulated secretion of uPA and MMP-9.

Conclusion. Src, ERK, and PLD are suggested as mediators of KGF-induced invasion in SNU-16. uPA and MMP-9 are considered as downstream targets of Src and ERK whereas PLD is thought to utilize different pathways.

Keywords: Keratinocyte growth factor Invasion Src ERK Phospholipase D

Footnotes

Electronic Publication


Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES